You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Chapter title |
Targeted therapy of the epidermal growth factor receptor in the treatment of pancreatic cancer.
|
|---|---|
| Chapter number | 15 |
| Book title |
Pancreatic Cancer
|
| Published in |
Recent results in cancer research Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer, January 2008
|
| DOI | 10.1007/978-3-540-71279-4_15 |
| Pubmed ID | |
| Book ISBNs |
978-3-54-071266-4, 978-3-54-071279-4
|
| Authors |
Heeger, S, Steffen Heeger, Heeger, Steffen |
| Abstract |
The epidermal growth factor receptor (EGFR)-mediated pathway is one of the most promising targets for the development of new strategies in anticancer treatments. The so-called "small molecule" tyrosine kinase inhibitor erlotinib has gained marketing authorization in the United States for advanced adenocarcinoma of the lung and for pancreatic cancer, whereas the antibody cetuximab is registered for metastatic colorectal cancer and cancers of the head and neck. Ongoing studies are evaluating the impact of EGFR-targeting therapy in the treatment of locally advanced and metastatic pancreatic cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 9 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 2 | 22% |
| Student > Ph. D. Student | 2 | 22% |
| Student > Master | 2 | 22% |
| Researcher | 1 | 11% |
| Professor > Associate Professor | 1 | 11% |
| Other | 1 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 67% |
| Agricultural and Biological Sciences | 2 | 22% |
| Social Sciences | 1 | 11% |